2026 NPPES data Genetic Counselor (M.S.) NPI 1194094995 MD, MS
Verify on CMS →

KAYLA FOURZALI, MD, MS

Genetic Counselor (M.S.) in MIAMI BEACH, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
15
Medicare Part D claims · Genetic Counselor (M.S.) avg: 134
Industry payments
$169.2
2 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

KAYLA FOURZALI, MD, MS filed 15 Medicare Part D claims in 2023 as a Genetic Counselor (M.S.) in MIAMI BEACH, Florida.

15
Part D claims, 2023
$169.2
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KAYLA FOURZALI, MD, MS's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

15 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about KAYLA FOURZALI, MD, MS?

Quality data not reported

NPI registry status

Active

Issued 12/22/2011

NPI 1194094995

Primary specialty

Genetic Counselor (M.S.)

Mid-sized

6,310 US NPIs in this specialty

Medicare Part D claims

15 89% vs specialty avg

2023 prescription claims

Specialty avg: 134

Specialty distribution in Florida

How Genetic Counselor (M.S.) compares to other specialties among Florida providers

Florida providers

Genetic Counselor (M.S.) share within Florida

1. Genetic Counselor (M.S.)42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Genetic Counselor (M.S.) share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Genetic Counselor (M.S.) (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Genetic Counselor (M.S.) ABMS/AOA estimate

Est. board-certified rate (Genetic Counselor (M.S.)) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Genetic Counselor (M.S.)) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KAYLA FOURZALI, MD, MS appears in the CMS NPPES registry as a Genetic Counselor (M.S.) provider holding MD, MS credentials at 4300 ALTON RD, MIAMI BEACH, FL, 33140, with a listed phone of (305) 606-7780. NPI 1194094995 was issued on 12/22/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FOURZALI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 15 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $624 in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Genetic Counselor (M.S.) is a mid-sized specialty nationwide, with 6,310 enrolled providers across 52 states and an average of 134 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4300 ALTON RD
MIAMI BEACH, FL 33140

Provider Details

NPI 1194094995
Specialty Genetic Counselor (M.S.)
Credentials MD, MS
Gender Female
NPI Issued 12/22/2011

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KAYLA FOURZALI, MD, MS. Source: openpaymentsdata.cms.gov.

Total received

$169

Largest payer

Boehringer Ingelheim Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to KAYLA FOURZALI, MD, MS. To verify KAYLA FOURZALI, MD, MS's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

15
Total Claims
$624
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
16
Total Day Supply
414
Brand Drug Cost
$0
Generic Drug Cost
$624

Patient Demographics

Average Patient Age
71.7 years
Avg HCC Risk Score
1.64

Genetic Counselor (M.S.) Overview

How KAYLA FOURZALI, MD, MS fits within the Genetic Counselor (M.S.) landscape nationally.

6,310
Genetic Counselor (M.S.) Providers in US
52
States with Genetic Counselor (M.S.)
134
Avg Claims per Provider

KAYLA FOURZALI, MD, MS's 15 claims are below the specialty average of 134.

Nearby Genetic Counselor (M.S.) Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as FOURZALI.

Compare Genetic Counselor (M.S.) nationally: see state-by-state distribution →

Frequently Asked Questions

What is KAYLA FOURZALI, MD, MS's specialty?
KAYLA FOURZALI, MD, MS specializes in Genetic Counselor (M.S.) and practices in MIAMI BEACH, Florida. Credentials: MD, MS.
How much does KAYLA FOURZALI, MD, MS prescribe under Medicare Part D?
In 2023, KAYLA FOURZALI, MD, MS wrote 15 Medicare Part D claims totaling $624 in drug costs for N/A beneficiaries.
Where is KAYLA FOURZALI, MD, MS located?
KAYLA FOURZALI, MD, MS is located at 4300 ALTON RD, MIAMI BEACH, FL, 33140. Phone: (305) 606-7780.
What is KAYLA FOURZALI, MD, MS's NPI number?
KAYLA FOURZALI, MD, MS's National Provider Identifier (NPI) is 1194094995, issued on 12/22/2011.
How many Genetic Counselor (M.S.) providers are there in the US?
There are 6,310 Genetic Counselor (M.S.) providers across 52 states in the US. The average Genetic Counselor (M.S.) provider writes 134 Medicare Part D claims per year.
Does KAYLA FOURZALI, MD, MS accept Medicare?
KAYLA FOURZALI, MD, MS appears in CMS Medicare data with 15 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KAYLA FOURZALI, MD, MS's credentials?
KAYLA FOURZALI, MD, MS's NPI is 1194094995 with credentials MD, MS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology